4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-021120
Director sold 51,343 shares at an average $10.34 ($530,811)
From the SEC's structured data for this filing
Trades in this filing
Canaan IX L.P. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-05-25 | Sale : show line 1 in the form | −11,456 | $10.02 | $114,789 | 4,551,359 | I |
| 2016-05-26 | Sale : show line 2 in the form | −39,887 | $10.43 | $416,021 | 4,511,472 | I |
| Open-market sales · 51,343 sh · avg $10.34 · $530,811 | ||||||
Loading xslF345X03/doc4.xml…